Medicare Enrolled
Dr. Le Wang, MD
Medical Oncology · Phoenixville, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wang?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wang
Dr. Le Wang is a medical oncology specialist in Phoenixville, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Wang performed 17,343 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Wang received a total of $3,603 from 34 pharmaceutical and/or device companies across 112 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 9% volume in PA
$3,603 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗17,343
Medicare services
Top 9% in PA for medical oncology
Not available
Unique patients (not deduplicated)
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,182 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 2,710 | $0 | $12 |
| Denosumab injection (Prolia/Xgeva) | 2,520 | $18 | $36 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
983 | $8 | $18 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
961 | $8 | $35 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
875 | $104 | $146 |
| Anti-nausea injection (Aloxi/palonosetron) | 840 | $1 | $50 |
| 5% dextrose/water (500 ml = 1 unit) | 812 | $1 | $3 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
741 | $26 | $125 |
| Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 545 | $2 | $15 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
433 | $1 | $4 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
428 | $11 | $100 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
407 | $1 | $2 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
334 | $118 | $460 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
311 | $0 | $12 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
192 | $12 | $70 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
180 | $1 | $2 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
178 | $18 | $75 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
176 | $14 | $75 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
173 | $56 | $200 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
142 | $67 | $135 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
59 | $148 | $190 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
52 | $111 | $275 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
44 | $1 | $8 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
38 | $136 | $256 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
16 | $4 | $20 |
| New patient office visit, complex (60-74 min) | 11 | $190 | $322 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
13.1% high complexity
59.9% medium
27.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,603
Total received (2018-2024)
Avg $515/year across 7 years
Top 49% in PA for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
112
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$468
2023
$584
2022
$707
2021
$339
2020
$397
2019
$621
2018
$487
Payments by company (2024)
Exelixis Inc.
$241
Lilly USA, LLC
$132
PFIZER INC.
$33
Merck Sharp & Dohme LLC
$17
Tempus AI, Inc
$16
Genentech USA, Inc.
$16
Blueprint Medicines Corporation
$13
Top 3 companies account for 86.6% of 2024 payments
All-time payments by company (2018-2024) ›
Seagen Inc.
$347
E.R. Squibb & Sons, L.L.C.
$326
Amgen Inc.
$325
Lilly USA, LLC
$325
Incyte Corporation
$294
Exelixis Inc.
$253
PFIZER INC.
$225
Janssen Biotech, Inc.
$214
Sunovion Pharmaceuticals Inc.
$117
Gilead Sciences, Inc.
$112
Allergan, Inc.
$99
Seattle Genetics, Inc.
$94
Allergan Inc.
$94
Janssen Pharmaceuticals, Inc
$82
BeiGene USA, Inc.
$80
AVEO Pharmaceuticals, Inc.
$76
Pharmacyclics LLC, An AbbVie Company
$76
Genentech USA, Inc.
$66
Bayer HealthCare Pharmaceuticals Inc.
$55
AstraZeneca Pharmaceuticals LP
$43
GENZYME CORPORATION
$39
Merck Sharp & Dohme LLC
$37
AbbVie, Inc.
$32
Novocure Inc.
$32
Clovis Oncology, Inc.
$26
Tactile Systems Technology Inc
$18
Tempus AI, Inc
$16
ARRAY BIOPHARMA INC
$16
Sobi, Inc
$16
Eisai Inc.
$15
Aadi Bioscience, Inc.
$14
Novartis Pharmaceuticals Corporation
$14
Blueprint Medicines Corporation
$13
Karyopharm Therapeutics Inc.
$12
Top 3 companies account for 27.7% of all-time payments
Associated products mentioned in payments ›
AVYCAZ · AYVAKIT · Alecensa · BRUKINSA · CABOMETYX · CALQUENCE · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · ELIQUIS · ELITEK · ERBITUX · ERLEADA · FOTIVDA · Flexitouch Plus · Fyarro · Gazyva · IBRANCE · IMBRUVICA · IMFINZI · Imbruvica · KEYTRUDA · LONHALA MAGNAIR · LORBRENA · Lenvima · Nexavar · NovoTTF-100L · Nplate · OPDIVO · ORGOVYX · PIQRAY · Perjeta · RETEVMO · Rubraca · SARCLISA · Stivarga · TECENTRIQ · TEFLARO · TUKYSA · Trodelvy · VERZENIO · Venclexta · XARELTO · XPOVIO · XTANDI · Xofigo
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
109
County median income
$123,041
Nearest hospital to ZIP centroid (approximate)
PHOENIXVILLE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wang is a mixed practice specialist, with above-average Medicare volume (top 9% in PA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wang experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Wang performed 3,182 dexamethasone injection (steroid) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Wang receive payments from pharmaceutical companies?
Yes. Dr. Wang received a total of $3,603 from 34 companies across 112 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wang's costs compare to other medical oncologists in Phoenixville?
Dr. Wang's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Phoenixville
Browse medical oncologists in Phoenixville ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in PA
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in PA
Which PA medical oncologists receive the most from drug and device companies.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology